Last news
Everest Medicines Announces Partner Calliditas Therapeutics Reports Positive Topline Results from Phase 3 NefIgArd Trial Evaluating Nefecon in IgA Nephropathy

Everest Medicines Announces Partner Calliditas Therapeutics Reports Positive Topline Results from Phase 3 NefIgArd Trial Evaluating Nefecon in IgA Nephropathy

...

AnnJi Pharmaceutical Announced Licensing Agreement With Avenue Therapeutics To Develop And Commercialize AJ201, A First-In-Class Clinical Asset For The Kennedy's Disease Treatment

AnnJi Pharmaceutical Announced Licensing Agreement With Avenue Therapeutics To Develop And Commercialize AJ201, A First-In-Class Clinical Asset For The Kennedy's Disease Treatment

...

Asendia Launches e-PAQ Select for Oceania E-commerce Market

Asendia Launches e-PAQ Select for Oceania E-commerce Market

...

Ankura Appoints Dana White to Lead Global Strategic Advisory Group

Ankura Appoints Dana White to Lead Global Strategic Advisory Group

...

Telix's ZIRCON Phase III Kidney Cancer Imaging Study Presented in "Game Changing" Session at EAU

Telix's ZIRCON Phase III Kidney Cancer Imaging Study Presented in "Game Changing" Session at EAU

...

Yalla Group Limited Announces Unaudited Fourth Quarter and Full Year 2022 Financial Results

Yalla Group Limited Announces Unaudited Fourth Quarter and Full Year 2022 Financial Results

...

Baijiayun Group Ltd Completes Transition into a Pure-play RTC Provider with Divestiture of Fuwei Films

Baijiayun Group Ltd Completes Transition into a Pure-play RTC Provider with Divestiture of Fuwei Films

...

VENTURE GLOBAL ANNOUNCES FINAL INVESTMENT DECISION AND FINANCIAL CLOSE FOR PHASE TWO OF PLAQUEMINES LNG

VENTURE GLOBAL ANNOUNCES FINAL INVESTMENT DECISION AND FINANCIAL CLOSE FOR PHASE TWO OF PLAQUEMINES LNG

...

menu
menu